Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Beats on EPS, Stock Down 1.17%

Collegium Pharmaceutical reported a positive surprise in EPS, exceeding expectations by over 35%. However, the stock reacted negatively, declining by 1.17%. This suggests that while the earnings performance was strong, other factors may have influenced investor sentiment.